The global drug delivery devices market is evolving rapidly as healthcare providers increasingly adopt technologies that improve treatment precision, patient safety, and medication adherence. The growing burden of chronic diseases, rising demand for self-administration devices, and continuous innovation in drug delivery technologies are creating significant growth opportunities across the healthcare industry.

Market Highlights

• Market Size (2025): USD 463.8 Billion 

• Estimated Market Size (2026): USD 498.0 Billion 

• Forecast Market Size (2033): USD 841.4 Billion 

• Growth Rate: CAGR of 7.8% (2026–2033) 

• Largest Product Segment: Inhalers (23.9% revenue share in 2025) 

• Largest Application: Diabetes (21.0% revenue share) 

• Largest End-use: Hospitals (28.9% revenue share) 

• Largest Regional Market: North America (32.4% revenue share) 

Why Is the Market Growing?

Several healthcare trends are contributing to the increasing demand for drug delivery devices.

Rising Burden of Chronic Diseases

The growing number of patients suffering from diabetes, cardiovascular diseases, respiratory disorders, cancer, and autoimmune diseases has significantly increased the need for reliable drug administration systems.

Long-term therapies require devices that improve treatment accuracy while reducing the risk of medication errors.

Shift Toward Home-Based Healthcare

Healthcare is gradually moving beyond hospitals.

Patients increasingly prefer therapies that can be safely administered at home, reducing hospital visits and improving convenience.

This trend has accelerated demand for:

• Auto-injectors 

• Pen injectors 

• Wearable infusion pumps 

• Portable inhalers 

• Self-injection devices 

Home healthcare is expected to remain one of the strongest drivers of future market growth.

Download a free sample copy of the Drug Delivery Devices Market report to understand detailed coverage and inclusions in the final report

Precision Medicine Is Increasing Device Demand

Modern therapies often require highly accurate drug administration.

Drug delivery devices help healthcare professionals deliver medications with greater precision while improving therapeutic effectiveness.

This is particularly important for:

• Biologics 

• Oncology drugs 

• Insulin therapies 

• Specialty pharmaceuticals 

As personalized medicine expands, advanced delivery systems will become increasingly important.

Product Insights

Drug delivery devices are available in several forms, each designed for specific therapeutic applications.

Inhalers Lead the Market

Inhalers accounted for 23.9% of global revenue in 2025.

Growing cases of asthma and chronic obstructive pulmonary disease (COPD) continue supporting demand for inhalation devices.

Manufacturers are introducing:

• Digital inhalers 

• Breath-actuated inhalers 

• Smart inhaler monitoring systems 

These products improve medication adherence while helping patients better manage respiratory conditions.

Injectable Devices Continue to Expand

Injectable drug delivery systems are experiencing rapid adoption due to the increasing use of biologic medicines.

Popular products include:

• Auto-injectors 

• Prefilled syringes 

• Pen injectors 

• Wearable injectors 

These devices simplify treatment while allowing patients to administer medications with minimal clinical assistance.

Application Trends

Drug delivery devices are widely used across numerous therapeutic areas.

Diabetes Remains the Largest Segment

According to Grand View Research, diabetes represented 21.0% of total market revenue in 2025.

The growing diabetic population continues to drive demand for insulin pens, insulin pumps, wearable injectors, and continuous drug delivery systems.

Other important applications include:

• Respiratory diseases 

• Oncology 

• Cardiovascular disorders 

• Infectious diseases 

• Autoimmune disorders 

End-use Analysis

Hospitals Continue to Lead

Hospitals generated the largest revenue share of 28.9% in 2025.

The availability of advanced treatment facilities, skilled healthcare professionals, and complex drug therapies continues to support hospital demand.

However, ambulatory care centers and home healthcare settings are becoming increasingly important as healthcare delivery becomes more decentralized.

Major Industry Trends

Several technological advancements are reshaping the future of drug delivery.

• Smart Drug Delivery: Manufacturers are integrating digital technologies that help patients monitor medication schedules while enabling healthcare providers to track treatment adherence remotely.

• Wearable Devices: Wearable drug delivery systems allow continuous medication administration with minimal patient intervention.

• Needle-Free Technologies: Needle-free injection systems are gaining attention because they improve patient comfort while reducing needle-related anxiety.

• Connected Healthcare: Integration with smartphones and digital health platforms enables real-time monitoring and personalized treatment management.

Geographic Landscape 

North America accounted for the largest revenue share of 32.4% in 2025, supported by advanced healthcare infrastructure, high adoption of innovative medical technologies, and increasing prevalence of chronic diseases.

Meanwhile, Asia Pacific is projected to register the fastest growth during the forecast period. Expanding healthcare access, rising pharmaceutical manufacturing, increasing healthcare expenditure, and growing patient awareness are creating significant opportunities across China, India, Japan, and other regional markets.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Competitive Landscape

The drug delivery devices market remains highly competitive, with leading companies investing in research, digital health integration, and next-generation delivery technologies. 

Major companies include:

• Abbott 

• Medtronic 

• Becton, Dickinson and Company (BD) 

• Boston Scientific Corporation 

• Gerresheimer AG 

• Terumo Medical Corporation 

• Teleflex Incorporated 

• Novartis AG 

• Stryker 

• W. L. Gore & Associates, Inc. 

These companies are focusing on smart delivery technologies, wearable devices, digital healthcare integration, and patient-friendly product designs.

Explore our dedicated business services:

• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.

• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.

• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.

• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics

• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology

• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us: 

Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.